An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients.

CompletedOBSERVATIONAL
Enrollment

808

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Routine clinical practice

Trial Locations (15)

100034

Peking University First Hospital, Beijing

100035

Beijing Jishutan Hospital; Rheumatology & Immunology, Beijing

100044

Peking University People's Hospital, Beijing

100083

Peking University Third Hospital, Beijing

130031

China-Janpan Friendship Hospital of Jilin University, Changchun

200052

Guanghua Hospital of Integrated Traditional Chinese and Western Medicine ( Guanghua Hospital), Shanghai

300052

Tianjin Medical University General Hospital, Tianjin (天津)

510080

The First Affiliated Hospital, Sun Yat-sen University, Guangzhou

510405

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou

510515

Nanfang Hospital, Southern Medical University, Guangzhou

610041

West China Hospital, Sichuan University, Chengdu

610072

Sichuan Provincial People's Hospital, Chengdu

710061

First Affiliated Hospital of Medical College of Xi'an Jiaotong University, Xi'an

830001

Xinjiang Uygur Autonomous Region People Hospital, Ürümqi

030001

The Second Hospital of Shanxi Medical University, Taiyuan

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT02590562 - An Observational Study to Describe in Routine Clinical Practice the Treatment Patterns of Usage of Biological DMARDs in RA Patients. | Biotech Hunter | Biotech Hunter